• OPEN AN ACCOUNT
Indian Indices
Sensex
78,449.27 482.92
( 0.62%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,825.49 -18.70
(-0.17%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Zensar Technologies Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
504067
INE520A01027
154.7366876
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZENSARTECH
15.72
11251.46
EPS(TTM)
Face Value()
Div & Yield %
31.46
2
3.02
 

Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
May 29,2026
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.7310.43 -13.9212.16 -
PBDT14.409.10 58 55.2432.53 70
PBT11.257.26 55 47.0027.49 71
NP10.786.00 80 32.6219.74 65